Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Weighted-Average Shares Outstanding (Diluted) of 1.07M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-15.80M |
|
-- |
|
-- |
|
$16.29M |
|
$-16.29M |
|
$0.49M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-16.29M |
|
$-16.19M |
|
1.07M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.07M |
$-14.80 |
|
$-14.80 |
|
| Balance Sheet Financials | |
$20.01M |
|
-- |
|
$0.38M |
|
$20.39M |
|
$5.55M |
|
-- |
|
$1.72M |
|
$7.27M |
|
$13.12M |
|
$12.74M |
|
$13.12M |
|
0.26M |
|
| Cash Flow Statement Financials | |
$-13.54M |
|
$-4.28M |
|
$18.01M |
|
$3.62M |
|
$3.82M |
|
$0.19M |
|
$1.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-120.46% |
|
-124.09% |
|
-77.51% |
|
-120.46% |
|
$51.32 |
|
$-12.68 |
|
$-12.68 |
|